Knowledge Base - Massachusetts Biotechnology Council - Massachusetts Biotechnology Council

WEBINAR: Strategic considerations for clinical development programs in emerging biopharma companies October 6, 2016 in Presentation & Video Library

Learn from Quintiles expert Dr. Rick Sax as he discusses strategic considerations emerging biopharma companies should tackle in early phase drug development through the lens of their investors. Specific elements include... Read More

Simplifying the complexities of global rare disease drug development September 30, 2016 in Presentation & Video Library

WEBINAR: Simplifying the complexities of global rare disease drug development Read More

The Comprehensive In Vitro Proarrhythmia Assay (CiPA) Guide Charles River Laboratories September 15, 2016 in White Papers,

FDA

The Comprehensive in vitro Proarrhythmia Assay (CIPA) initiative is expected to reduce unwarranted drug discovery attrition, improve accuracy in predicting cardiac risk and ultimately make better, safer drugs to benefit... Read More

2016 MassBio Industry Snapshot August 24, 2016 in White Papers,

The number of drug candidates in clinical trials from Massachusetts-headquartered companies increased by 14% from 2014, and the total number of drug candidates increased to 1,645, a 10% increase, according to an annual... Read More

Download Attachment

Do you want to cash in on your R&D credit? WithumSmith+Brown August 4, 2016 in Advisories,

The life science industry can utilize the re-designed R&D credit by applying the credit toward their payroll tax liability rather than their income tax. Read More

RQMIS Regulatory Consultation Expertise RQMIS, Inc. July 21, 2016

RQMIS Expertise Centers - Helping Your Team Exceed Goals - RQMIS can deliver in the areas of regulatory strategy/submissions, clinical study design/management, quality systems design/compliance and regulatory/quality system... Read More

Direct-to-Patient Shipping Toolkit July 21, 2016 in White Papers,

Wondering what the new direct-to-patient shipping innovation is and how you next study could benefit? Read More

FDA's Expedited Programs July 7, 2016 in White Papers,

FDA,
MassBioEd

Through development of the expedited programs, FDA provides companies with the resources needed to accelerate the drug approval process. In this white paper, we explore the benefits of each program and provide guidance... Read More

CONDUCTING EARLY PHASE TRIALS IN SCHIZOPHRENIA PRA Health Sciences June 23, 2016 in White Papers

Challenges and Strategies for Conducting Early Phase Trials in Schizophrenia Read More

Translating Cancer Genomics Into a Personalized Approach for Cancer Patients PRA Health Sciences June 23, 2016 in White Papers,

This white paper provides a brief history of oncology genomics, including development, uses in improving patient care, current achievements and challenges, and the future direction of cancer genomics. Read More